Explore 3 Stock Ideas & Industry Insights Download Free Report
XL Fleet Corp (NYSE: XL)
Technical Outlook: XL’s prices have been under pressure from an all-time high and made a low of USD 5.41 on 13 May 2021. Prices recently started to move upward after forming a bullish engulfing (bullish reversal) candlestick pattern on a weekly time frame chart, which indicates the possibility of a change in the trend to the upside.
On the weekly chart, the momentum indicator RSI (14-period) is trading near at ~38.03 level and recovering from the lower level. Prices also formed a positive divergence with the RSI, further supporting a positive direction. Moreover, during the last week, the volume in the stock is showing an upward trend, which indicates higher participation from the investors. However, prices are trading below the trend-following indicators 21-period SMA and 50-period SMA. Now an immediate resistance level for XL is at USD 9.10 and prices may test the level in the short term. On the lower side, USD 5.40 acting as an immediate support level.

As per the above-mentioned price action and technical indicators analysis, we can conclude that XL Fleet Corp is looking technically well-placed on the chart and we have a ‘Speculative Buy’ rating on the stock. The summary of our recommendation is as follow:

Analysis: Kalkine Group
Sorrento Therapeutics Inc (NASDAQ: SRNE)
Technical Outlook: SRNE's prices broke a falling wedge pattern by an upside on May 20, 2021, and since then, prices are hovering around the breakout level, indicating an upward direction for the stock. Prices also formed a positive divergence with the RSI (14-period) and supporting a positive stance.
On a daily chart, the leading indicator RSI (14-period) is trading in positive territory at ~56.10 levels. Prices recently moved above the trend-following indicators 21-period SMA and 50-period SMA, further indicating an upward movement for the stock. The MACD line is trading below the centerline with a positive crossover. Now the next major resistance level for SRNE is at USD 9.10 and prices may test the level in the short term. On the lower side, USD 6.57 acting as an immediate support level.

As per the above-mentioned price action and technical indicators analysis, we can conclude that Sorrento Therapeutics Inc is looking technically well-placed on the chart and we have a ‘Speculative Buy’ rating on the stock. The summary of our recommendation is as follow:

Analysis: Kalkine Group
Technical Outlook: On the daily chart, PLTR’s prices are recovering from lower levels and broke a major resistance level of USD 21.50 on May 26, 2021. Prices are continuously trading upside after taking the support of an upward sloping trend and indicating a positive direction in the coming sessions.
The momentum indicator RSI (14-period) is trading at ~57.10 level and indicates positive momentum for the stock prices. Volumes in the stock are showing an increasing trend, which indicates higher participation from the investors. Meanwhile, prices are trading above the trend-following indicators 21-period SMA. Now an immediate resistance level for PLTR is at USD 26.63 and prices may test the level in the short term. On the lower side, USD 19.40 acting as an immediate support level.

As per the above-mentioned price action and technical indicators analysis, we can conclude that Palantir Technologies Inc. is looking technically well-placed on the chart and we have a ‘Speculative Buy’ rating on the stock. The summary of our recommendation is as follow:

Analysis: Kalkine Group
Note: Support level can be considered as an indicative stop-loss, and if prices move below that level on closing basis investors may evaluate exiting the position. Resistance level can be considered as a Target Price for the stock. Investment decision should be made based on an Investors' risk appetite, previous holdings, and other factors considered.
Kalkine Equities LLC provides general information about companies and their securities. The information contained in the reports, including any recommendations regarding the value of or transactions in any securities, does not take into account any of your investment objectives, financial situation or needs. Kalkine Equities LLC is not registered as an investment adviser in the U.S. with either the federal or state government. Before you make a decision about whether to invest in any securities, you should take into account your own objectives, financial situation and needs and seek independent financial advice. All information in our reports represents our views as at the date of publication and may change without notice.
Kalkine Media LLC, an affiliate of Kalkine Equities LLC, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Past performance is not a reliable indicator of future performance.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!